Lisdexamfetamine

Lisdexamfetamine Reactions 1680, p204 - 2 Dec 2017 Anxiety with recurrence and aggravation of night terror: case report A 23-year-old man experienced anxiety with recurrence and aggravation of night terror during treatment with lisdexamfetamine [route, dosage and indication not stated]. The man, who had a history of childhood night terrors, reported recurrence of night terror just a month after the initiation of lisdexamfetamine therapy. During childhood, he used to had night terrors at an interval of three to four times per year, whereas currently he was experiencing recurrence three to five times per week. At presentation, he had a BP of 140/96 and a pulse of 105 [units not stated]. His mental status examination showed anxious mood with congruent affect. On anamnesis, he reported night terror as a black figure appearing next to the door or the bed. At that time, he was unable to speak or to move. Then, he shouted loudly. Thereafter, his parents woke him up from terror sleep [outcomes not stated]. Author comment: "Possibly, [lisdexamfetamine] acted to precipitate night terrors by functioning as a dopamine receptor agonist." "Lisdexamfetamine may be inducing night terror indirectly through enhancement of anxiety." Makwana MN, et al. The incubus strikes again: Recurrence of sleep terrors with lisdexamfetamine administration. CNS Spectrums 22: 84-85 (plus poster) abstr. 140, No. 1, 7 Feb 2017. Available from: URL: http://doi.org/10.1017/ S1092852916000900 [abstract] - India 803284805 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Lisdexamfetamine

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/lisdexamfetamine-rtVbB0iVpp
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39135-6
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial